FemTech benchmarks: market size and the marketing channels that pay back

FemTech, short for female technology, covers products, software, diagnostics and services designed around women's health. That includes reproductive health and contraception, pregnancy and nursing, fertility, menopause, sexual health and general health care, delivered as devices, apps, testing kits or care platforms.

Grand View Research reports that approximately 50% of femtech companies operate in reproductive health and contraception, pregnancy and nursing, and general health care, and that pregnancy and nursing solutions, such as Expectful, make up 21% of the U.S. market.

For marketers, the defining trait is not the product but the rules around it. Ad platforms restrict claims about bodies, hormones and sex, so FemTech brands often cannot use the paid playbook that works for other consumer health products. That is why Wellness Marketing Benchmarks tracks channel performance alongside market size.

Three structural facts shape FemTech marketing. First, devices lead by type at 33.4% of the global market in 2025, and devices are exactly the products that ad platforms review most strictly when they touch sexual or reproductive health. Second, direct-to-consumer is the largest end use at 30.7%, so most of these brands need consumer acquisition, not just clinical sales.

Third, money is scarce. Grand View Research reports that women's health has historically received only about 2% of health tech funding. Combine a direct-to-consumer model with restricted ads and thin budgets, and channel efficiency becomes the deciding factor in growth.

That is where the interview findings in the next section come in: they show which channels FemTech and sexual wellness founders actually rely on.